Michael George, MD, MSCE
Dr. George’s research is focused on pharmacoepidemiology, with a particular interest in the risk of infections with immunosuppression in patients with autoimmune diseases such as rheumatoid arthritis. He studies the risk of infections and other adverse outcomes with low doses of glucocorticoids, which are commonly used in the treatment of many autoimmune diseases, and is interested in how this compares to risk with newer targeted therapies. His research includes evaluating the use of immunosuppression in high risk populations, such as patients undergoing major surgical procedures.
In addition, Dr. George is currently recruiting patients from an online patient registry to study how different therapies impact the risk of common colds and other outpatient infections and the impact of these on patient reported outcomes.
Rheumatology, rheumatoid arthritis, immunosuppression, interstitial lung disease
Pharmacoepidemiology, propensity scores, causal inference